Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile 

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

          1. Title: CAR T cells in solid tumors: challenges and opportunities
              Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
              Year: 2021
              Citations: 611

          2. Title: Nanoparticulate drug-delivery systems: an overview
              Authors: D. Thassu, Y. Pathak, M. Deleers
              Year: 2007
              Citations: 349

          3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
              Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
              Year: 2021
              Citations: 310

         4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
             Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
             Year: 2021
             Citations: 279

         5. Title: Drug delivery nanoparticles formulation and characterization
             Authors: Y. Pathak, D. Thassu
             Year: 2009
             Citations: 224

          6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
              Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
             Year: 2021
             Citations: 195

         7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
             Authors: A. Barkai, Y.V. Pathak, S. Benita
             Year: 1990
             Citations: 169

         8. Title: Ocular drug delivery: impact of in vitro cell culture models
             Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
             Year: 2016
             Citations: 165

         9. Title: Surface modification of nanoparticles for targeted drug delivery
             Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
             Year: 2019
             Citations: 139

       10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
             Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
             Year: 2009
             Citations: 112

 

 

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Joseph M Pappachan, Manchester Metropolitan University, United Kingdom

Prof. Dr. Joseph M. Pappachan is an internationally acclaimed endocrinologist and physician-scientist with profound contributions to metabolic and endocrine disorders. With over two decades of clinical, academic, and research experience, he currently serves at the Department of Endocrinology, Amrita Institute of Medical Sciences, India. His work bridges the gap between clinical practice and groundbreaking research, particularly in diabetes, obesity, metabolic syndrome, and endocrine hypertension. 📊 He has authored numerous high-impact publications and book chapters, and actively contributes to peer-reviewed journals as an editor and reviewer. Prof. Pappachan’s research is widely cited, reflecting his global influence in the field. 🌍 Known for his mentorship and academic leadership, he has trained many budding endocrinologists and researchers. His dedication to innovation and translational research has earned him multiple accolades and fellowships. 🧪 A dynamic scholar and clinician, Prof. Pappachan embodies excellence, integrity, and impact in the medical research community.

Publication Profile

Google Scholar

Education

Prof. Dr. Joseph M. Pappachan holds an MBBS degree from Government Medical College, Calicut, and completed his MD in Internal Medicine from Government Medical College, Trivandrum. 🏥 He further specialized in Endocrinology with a DM from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. 📘 In pursuit of global medical standards, he earned Membership of the Royal College of Physicians (MRCP) in the UK and became a Fellow of the Royal College (FRCP) and Fellow of the American College of Endocrinology (FACE). 🎖️ Prof. Pappachan has also undergone advanced training in endocrinology and diabetes in the United Kingdom and Europe, further honing his expertise in clinical research and metabolic diseases. 🌍 His commitment to lifelong learning is evident in his pursuit of continuing medical education and participation in international research fellowships, solidifying his position as an educator and research innovator in the medical sciences.

Experience

With over 20 years in clinical practice and academic research, Prof. Pappachan has served in leading institutions in India and the UK. 🏥 He is currently a Senior Consultant and Professor at the Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi. Previously, he held several academic positions in NHS hospitals and universities across the United Kingdom, where he actively participated in clinical trials and interdisciplinary research. 🌐 His professional journey includes experience in tertiary referral centers for complex endocrine and metabolic disorders. Prof. Pappachan is a sought-after speaker in national and international medical conferences and frequently leads CME programs for physicians. 🗣️ He also serves on the editorial boards of prominent journals and contributes significantly to peer-review processes. 🖋️ His extensive experience in patient care, medical education, and translational research makes him a respected authority in endocrinology worldwide.

Awards and Honors

Prof. Pappachan’s excellence in research has been recognized through numerous awards, fellowships, and international honors. 🏅 He has received the Fellowship of the Royal College of Physicians (FRCP), Fellowship of the American College of Endocrinology (FACE), and prestigious research grants for his work in metabolic disorders. 🎓 His research publications have garnered thousands of citations, and he ranks among the top Indian scientists in endocrinology. 📊 He has served as an expert panel member for international bodies and contributes to the development of clinical guidelines in diabetes and metabolic syndrome. 🌟 As an editorial board member and peer reviewer for several high-impact journals, his insight is valued across the medical research spectrum. 🧬 His outstanding contributions to patient care, research, and academic mentorship have earned him wide acclaim and nominations for top medical awards, making him a truly deserving candidate for the Best Researcher Award.

Research Focus

Prof. Pappachan’s research primarily centers on diabetes mellitus, obesity, metabolic syndrome, thyroid disorders, and hypertension, with a strong emphasis on the interplay between endocrine function and metabolic health. 🔍 His pioneering work investigates mechanisms of insulin resistance, neuroendocrine regulation, and cardiometabolic risk in various populations. His translational research explores clinical applications of novel diagnostic tools, therapeutic strategies, and biomarker discovery. 🧪 He has also examined sleep disorders and circadian rhythm disruptions in metabolic diseases and their implications for treatment outcomes. 🌙 His extensive publications focus on patient-centered interventions and the development of global clinical protocols. 📋 With multidisciplinary collaboration, Prof. Pappachan continues to advance understanding in precision medicine and evidence-based endocrinology, contributing significantly to the global discourse on metabolic and endocrine diseases. 🌐 His research is transformative, clinically relevant, and instrumental in shaping modern endocrine care.

Publication Top Notes

Omega-3 fatty acids: a comprehensive review of their role in health and disease

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

Diabetes mellitus and stroke: a clinical update

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study

Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes

Male obesity-related secondary hypogonadism–pathophysiology, clinical implications and managementMedicine and Health Sciences

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …